Home › Medical Devices
Medical Devices Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Cold Pain Therapy Market by Product (OTC (Gels, Sprays, Patches, Cold Packs, Wraps, Pads, and Roll-Ons), Prescription-Based (Motorized, Non-Motorized Devices), Applications (Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine, and Post-Trauma Therapy) - Global Forecast to 2023The global cold pain therapy market is projected to reach USD 2.12 Billion by 2023 from USD 1.69 Billion in 2018, at a CAGR of 4.6%. The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold pain therapy products during the study period. As of 2017, the major players in the cold pain therapy market are Sanofi (France), DJO Finance (US), and Pfizer (US). Other players in this market include 3M (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Beiersdorf (Germany) Rohto Pharmaceutical (US), Breg (US), Romsons Group of Industries (India), Custom Ice (US), and Unexo Life Sciences (India). |
June 2018 | $ 5650 |
|
Sterilization Equipment Market by Product & Service (Instrument (Heat, Filtration, Low Temperature), Consumables and Accessories (Detergents, Indicators), Services (E beam, Gamma)), End User (Hospitals, Pharmaceutical Companies) - Global Forecast to 2023The global sterilization equipment market is expected to reach USD 11.14 Billion by 2023 from USD 7.94 Billion in 2018, at a CAGR of 7.0%. The major factors driving the growth of this market are the rising incidence of hospital-acquired infections, increasing number of surgical procedures, rising focus on food sterilization and disinfection, technological advancements in sterilization equipment, and increasing number of hospitals in Asia. Key players in the sterilization equipment market include Steris Corporation (US), Getinge Group (Sweden), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), Cantel Medical (US), and Sterigenics International, Inc. (US) |
June 2018 | $ 5650 |
|
Angiography Equipment Market by Product (Angiography Systems, Catheters, Guidewire, Balloons, Contrast Media), Technology (X-Ray, CT, MRA), Procedure (Coronary, Endo, Neuro), Application (Diagnostic, Therapeutic), Patient Care Setting - Global Forecast to 2023The angiography equipment market is projected to reach USD 13.06 Billion by 2023 from USD 10.26 Billion in 2018, at a CAGR of 5.0%. The growth in this market is attributed to the high prevalence of diseases such as cancer and CVDs, increasing product approvals for advanced angiography techniques in the market, the large number of ongoing research activities, growing government and public-private investments, increasing number of awareness programs, and rising adoption of angiography devices due to a large number of angiography procedures performed across the globe. The key players in the angiography equipment market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (US), Cordis (a Cardinal Health Company, US), Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (US), B. Braun Melsungen (Germany), and Abbott Laboratories (US). |
June 2018 | $ 5650 |
|
Lithotripsy Devices Market by Type (ESWL, Intracorporal (Laser, Electrohydraulic, Mechanical, Ultrasonic Lithotripsy)), Application (Kidney, Ureteral, Bile Duct & Pancreatic Stones), End User (Hospital), Procedures - Global Forecast to 2023The global lithotripsy devices market is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%. Growth in this market is propelled by the increasing incidence of urolithiasis and technological advancements in lithotripsy devices. Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany). Key companies in the lubricating oil additives market include Afton Chemical (US), Chevron Oronite (US), BASF (Germany), Evonik Industries (Germany), Lubrizol Corporation (US), and Lanxess (Germany). |
June 2018 | $ 5650 |
|
Wound Care Biologics Market by Product (Biological Skin Substitutes (Biosynthetic Products), Topical Agents), Wound Type (Diabetic Foot Ulcer, Pressure Ulcers, Surgical & Traumatic Wound), End User (Hospitals, Burn Centers) - Global Forecast to 2023The global wound care biologics market is expected to reach USD 2.26 Billion by 2023 from USD 1.42 Billion in 2018, at a CAGR of 9.8%. Market growth is mainly driven by factors such as the increasing incidence of diabetic foot ulcers, increasing geriatric population, and increasing burn injuries globally. On the other hand, the high cost of wound care biologics and the higher rejection rate associated with skin grafts & substitutes will restrain the growth of this market. Key players in the wound care biologics market include Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), Lavior Inc. (US), and Marine Polymer Technologies, Inc. (US). |
June 2018 | $ 5650 |
|
Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023The global wound debridement market is expected to reach USD 1,041.0 Million by 2023 from USD 702.0 Million in 2018, at a CAGR of 8.2%. Factors such as rising incidence of diabetes & associated wounds, growing aging population, rising incidence of burn injuries, and growing awareness programs for wound care treatment and management are driving the growth of the wound debridement market. The major players in the wound debridement market include Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), Misonix (US), ConvaTec (UK), Lohmann & Rauscher (Germany), DeRoyal Industries (US), Medline Industries (US), Mölnlycke Health Care AB (Sweden), and Integra LifeSciences (US). |
May 2018 | $ 5650 |
|
Hernia Repair Market by Product (Mesh (Synthetic, Biologic), Mesh Fixation (Suture, Tack and Glue Applicator)), Surgery Type (Inguinal, Incisional/Ventral, Umbilical, Femoral), and Geography (America, Europe, Asia Pacific) - Forecast to 2023The hernia repair market is projected to reach USD 4.75 Billion by 2023 from USD 4.09 Billion in 2018, at a CAGR of 3.0% during the forecast period. The increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia repair market during the forecast period. The major players in the hernia repair market profiled in this report are Covidien ( Part of Medtronic) (Ireland), Ethicon (Part of Johnson & Johnson) (US), B. Braun (Germany), C.R. Bard (Part of Becton Dickinson) (US), W. L. Gore (US), LifeCell (Part of Allergan) (Ireland), Maquet (Part of Getinge) (Sweden), Cook Medical (US), Integra (US), DIPROMED (Italy), FEG (Germany), Cousin Biotech (France), Herniamesh (Italy), Aspide Medical (France), TransEasy Medical (China), and Via Surgical (Israel). |
May 2018 | $ 5650 |
|
Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023The global molecular diagnostics market is projected to reach USD 11.54 Billion by 2023 from USD 7.10 Billion in 2017, at a CAGR of 8.4%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. Growth in this market is primarily driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. The key players in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US). |
May 2018 | $ 5650 |
|
Bariatric Surgery Devices Market by Type (Minimally Invasive (Stapling, Suturing), Non-Invasive), Procedure (Sleeve Gastrectomy, Gastric Bypass, Revision Surgery, Adjustable Gastric Banding, Mini Gastric Bypass) - Global Forecast to 2023The global bariatric surgery devices market is projected to reach USD 2.16 Billion by 2023 from USD 1.64 Billion in 2018, at a CAGR of 5.7% during the forecast period. The growth of this market is driven by factors such as the growing obese population, increasing number of bariatric surgeries, and increasing preference for minimally invasive procedures. Ethicon (US), Medtronic (Ireland), Intuitive Surgical (US), Apollo Endosurgery (US), and ReShape Lifesciences, (US) are the key players in the bariatric surgery devices market. Other players involved in this market are Aspire Bariatrics (US), Mediflex Surgical Products (US), Spatz FGIA (US), Cousin Biotech (France), and Olympus Corporation of the Americas (US). |
May 2018 | $ 5650 |
|
Patient Monitoring Device/System/Equipment Market by Product (EEG, EMG, MEG, TCD, Peak Flow Meter, Pulse Oximeter, Fetal Monitoring, Temperature Monitoring Devices, MCOT, ECG, Hemodynamic Monitoring System), End User (Home, Hospital) - Global Forecast to 2023The patient monitoring devices market is projected to reach USD 25.31 Billion by 2023 from USD 19.14 Billion in 2018, at a CAGR of 5.7%. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period. The patient monitoring devices market is dominated by players such as Medtronic (Ireland), Abbott (US), Natus Medical (US), Nihon Kohden (Japan), GE Healthcare (US), and Philips Healthcare (Netherlands). |
May 2018 | $ 5650 |
|
Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) - Global Forecast to 2023The global adhesion barrier market is projected to reach USD 806.4 Million by 2023 from USD 570.7 Million in 2018, at a CAGR of 7.2%. The growth of this market is driven by the growth in the geriatric population and corresponding age-related chronic diseases, epidemiological shift from infectious to chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical complications occurred due to post-surgical adhesion formation. The key players in the global adhesion barrier market are Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea). |
May 2018 | $ 5650 |
|
Biological Safety Cabinet Market by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic & Research Institution) - Global Forecast to 2022The biological safety cabinets market is projected to reach USD 205.9 Million by 2022 from USD 144.3 Million in 2017, at a CAGR of 7.4% during the forecast period. Growth in the biological safety cabinets market is mainly driven by factors such as favorable regulations, increased risk of pandemics and communicable diseases, and pharmaceutical companies, and rapid growth in the number of biologics. The biological safety cabinets market is segmented on the basis of type, end user, and region. The major market players in the biological safety cabinets market include Thermo Fisher Scientific (US), Esco Micro (Singapore), Labconco (US), The Baker Company (US), Kewaunee Scientific (US), NuAire (US), Germfree Laboratories (US), EUROCLONE (Italy), Cruma (Spain), Air Science (US), Berner International (Germany), and BIOBASE (China). |
May 2018 | $ 5650 |
|
Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023The global point of care (POC) molecular diagnostics market is projected to reach USD 1440.2 Million in 2023 from USD 725.5 Million in 2018, at CAGR of 14.7%. POC molecular diagnostics are point-of-care setting devices used by healthcare professionals to detect and diagnose various diseases in humans. Some of the key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Biomerieux SA (France), and Danaher (US). Product development was the major strategy adopted by these major players to maintain their leadership position in the global POC molecular diagnostics market. |
May 2018 | $ 5650 |
|
Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022The global cerebrospinal fluid management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period. The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures. The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan). |
May 2018 | $ 5650 |
|
Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (Mad) & Tongue-Retaining Devices (TRD)), Type (Physician Prescribed/Customized Oral Appliances & Online OTC Oral Appliances) - Global Forecasts to 2023The sleep apnea oral appliances market is projected to reach USD 482.5 Million by 2023 from an estimated USD 233.2 Million in 2018. The major influencing factors driving the growth of this market are growing popularity of oral appliances in sleep apnea management, technological advancements in oral appliances, a large pool of undiagnosed sleep apnea patients, and growing awareness about sleep apnea. ResMed (US), SomnoMed (Australia), and Whole You (US) are the key players in the sleep apnea oral appliances market. Other players involved in this market are Oventus (Australia), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), DynaFlex (US), OravanOSA (US), and Myerson (US). |
May 2018 | $ 5650 |
|
Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User (Hospitals) – Global Forecast to 2023The global immunoassays market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments. Key players in the immunoassays market include Roche (Switzerland), Abbott Laboratories (US), Siemens (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), bioMérieux (France), Ortho Clinical Diagnostics (US), DiaSorin (Italy), QIAGEN (Netherlands), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), PerkinElmer (US), Quidel Corporation (US), Bio-Techne Corporation (US), and Mindray (China). |
May 2018 | $ 5650 |
|
Laparoscopic and Open Hernia Mesh Repair Surgery Market by Mesh Fixator (Glue And Tack Applicators), Country (US, Canada, Germany, France, UK, Italy, Spain, Japan, China, and India) - Forecast to 2022The laparoscopic and open hernia mesh repair surgery market is projected to reach USD 3.53 Billion by 2022 from USD 3.18 Billion in 2017, at a CAGR of 2.1% during the forecast period. The increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia mesh repair surgery market during the forecast period. The major players in the hernia mesh repair surgery market profiled in this report are Medtronic (Ireland), Johnson & Johnson (US), B. Braun (Germany), C. R. Bard (US), and W.L. Gore (US). |
May 2018 | $ 5650 |
|
Plastic Surgery Instruments Market by Type (Handheld (Forceps, Needle Holder, Scissors, Retractor), Electrosurgery (Bipolar, Monopolar)), Procedure (Cosmetic (Breast Augmentation, Face, Head, Extremities), Reconstructive), End User - Global Forecast to 2023The global plastic surgery instruments market is expected to reach USD 1,479.0 Million by 2023 from USD 1,002.0 Million in 2018, at a CAGR of 8.1%. Increasing awareness and demand for cosmetic surgeries, growing number of age-related surgeries across the globe, and increasing incidence of cancer are the key drivers of the global plastic surgery instruments market. The plastic surgery instruments market is highly fragmented with the presence of several large as well as emerging players. Prominent players in the plastic surgery instruments market include Sklar Surgical Instruments (US), KLS Martin Group (Germany), Integra LifeSciences Corporation (US), Tekno-Medical Optik-Chirurgie GmbH (Germany), KARL STORZ GmbH & Co. KG (Germany), Zimmer Biomet (US), B. Braun Melsungen AG (Germany), BMT Medizintechnik GmbH (Germany), Anthony Products, Inc. (US), Bolton Surgical Ltd. (UK), Surgicon Pvt. Ltd. (Pakistan), and Blink Medical (UK). |
May 2018 | $ 5650 |
|
Heart Pump Device Market by Product (Ventricular Assist Device (LVAD, RVAD, BiVAD, and pVAD), Intra Aortic Balloon Pump, TAH), Type (Extracorporeal and Implantable Pump), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2022The global heart pump devices market is projected to reach USD 3.98 Billion by 2022 from an estimated USD 1.64 Billion in 2017, at a CAGR of 19.4% during the forecast period. The growth of this market is majorly driven by factors such as growing prevalence of cardiovascular diseases, increasing number of regulatory approvals, and an acute shortage of donor hearts. The key players in the global heart pump devices market are St. Jude Medical (a subsidiary of Abbott Laboratories) (US), Abiomed (US), Medtronic (Ireland), Getinge (Sweden), Teleflex (US), ReliantHeart (US), BerlinHeart (Germany), Terumo (Japan), SynCardia Systems (US), TandemLife (CardiacAssist) (US), Jarvik Heart (US), and Fresenius Medical Care (Germany). |
May 2018 | $ 5650 |
|
Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022The global biomarker technologies market is expected to reach USD 74.51 Billion in 2022 from USD 42.88 Billion in 2016, at a CAGR of 9.7% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (Switzerland), Danaher Corporation (US), Waters Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US). |
May 2018 | $ 5650 |
|
EMEA 3D CBCT/Cone Beam CT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) - Forecast to 2023The EMEA 3D CBCT systems market is projected to reach USD 300.4 Million by 2023 from USD 194.3 Million in 2018, at a CAGR of 9.0%. The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region. This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems. The key players in the EMEA 3D CBCT systems market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea). |
May 2018 | $ 5650 |
|
Sternal Closure Systems Market by Product (Closure Devices (Wire, Plate, Screw, Cable,), Bone Cement), Procedure (Median Sternotomy, Hemisternotomy, Bilateral Thoracosternotomy), Material (Stainless Steel, Peek, Titanium) - Global Forecast to 2023The global sternal closure systems market is projected to reach USD 2.61 Billion by 2023 from USD 2.02 Billion in 2018, at a CAGR of 5.2% during the forecast period. Growing availability of medical reimbursements across major markets, technological advancements in sternotomy techniques, and increased target patient population with the subsequent increase in the number of surgical procedures are expected to drive the demand for sternal closure systems during the study period. As of 2017, the major players in the sternal closure systems market are DePuy Synthes (US), Zimmer Biomet Holdings (US), and A&E Medical (US). Other players in this market include KLS Martin Group (US), Orthofix International N.V. (US), ABYRX (US), Acute Innovations (US), Kinamed Incorporated (US), Praesidia Srl (Italy), and IDEAR S.R.L. (Argentina) among others. |
April 2018 | $ 5650 |
|
Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023The veterinary pain management market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care costs may be a key restraining factor for the market in the next five years. The prominent players in the veterinary pain management market are Zoetis (US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market |
April 2018 | $ 5650 |
|
Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022This report studies the angiographic catheters market based on application and region; end-user analysis; and competitive scenario. The market study covers the global angiographic catheters market from 2015 to 2022 and provides details of the factors influencing the market at both the macro- and micro-levels along with competitive developments and recent market trends. The report provides a detailed overview of the major drivers, restraints, opportunities, current market threats, and strategies impacting the growth of angiographic catheters market along with the estimates and forecasts of the revenue and market ranking analysis The global angiographic catheters market is expected to reach USD 1,402.8 Million by 2022 from USD 922.1 Million in 2016 and, at a CAGR of 7.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Key players operating in the angiographic catheters market include Medtronic (US), Boston Scientific (US), Terumo Medical (Japan), Cardinal Health (US), and Merit Medical System (US). |
April 2018 | $ 5650 |
|
Magnetic Resonance Imaging Systems Market by Architecture (Open MRI Systems and Closed MRI Systems (Standard Bore and Wide Bore)), Field Strength (Low-to-mid Field, High-field (1.5T and 3T), and Very-high Field) - Global Forecast to 2023The global MRI systems market is projected to reach USD 7.09 Billion by 2023 from USD 5.85 Billion in 2018, at a CAGR of 3.9%. Some key factors driving market growth include the increasing geriatric population, rising awareness about the benefits of early diagnosis, and the introduction of technologically advanced MRI systems with better image quality and high throughput. Factors such as novel application areas such as detection of metastasis in cancer, hybrid MRI systems and emerging markets are expected to offer lucrative growth opportunities for players in the MRI systems market. The major players in the global MRI systems market are Siemens Healthineers (Germany), GE Healthcare (US), Phillips (Netherlands), Hitachi (Japan), and Canon Medical Systems (Japan). |
April 2018 | $ 5650 |
|
Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device), Diagnostic (PSG, Oximeter)), End User (Sleep Laboratories & Hospitals, Home Care/Individuals) - Global Forecasts to 2023The sleep apnea devices market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018. The major influencing factors driving the growth of this market are increasing patient pool for sleep apnea on account of increasing obesity globally, improving patient compliance owing to stringent reimbursement regulations, increasing home sleep testing as well as initiatives to increase awareness globally. ResMed (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare (New Zealand) are the key players in the sleep apnea devices market. Other players involved in this market are SomnoMed (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Whole You (US), BMC Medical (China), Drive DeVilbiss Healthcare (US), and Braebon Medical (Canada). |
April 2018 | $ 5650 |
|
Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecast to 2023The global occlusion devices market is projected to reach USD 3.55 Billion by 2023 from USD 2.74 Billion in 2018, at a CAGR of 5.3%. The growth witnessed by occlusion devices is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for occlusion devices across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US). |
April 2018 | $ 5650 |
|
Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022The global infectious disease diagnostics market is projected to reach USD 19.35 Billion in 2022 from USD 14.73 Billion in 2017, at CAGR of 5.6%. Infectious disease diagnostics are various techniques used by healthcare professionals to detect and diagnose diseases causing pathogens in human samples such as serum, blood, urine, throat swab, and stool. Growth in this market is largely be driven by the increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMérieux (France), Bio-Rad (US), and Roche (Switzerland). |
April 2018 | $ 5650 |
|
Surgical Drapes and Gowns Market by Type (Drapes (Cardiovascular, General Surgery, C- Section, Lithotomy, Laparoscopy, Ophthalmic), Gown (Standard, Reinforced, High-Performance)), Utility (Reusable, Disposable), End User (Hospital) - Global Forecast to 2023The global surgical drapes and gowns market is expected to reach USD 3.14 Billion by 2023 from USD 2.47 Billion in 2018, at a CAGR of 4.9%. Major industry players launched innovative products to maintain and improve their position in the surgical drapes and gowns market. Cardinal Health (US), 3M (US), Mölnlycke Health Care (Sweden), Halyard Health (US), Thermo Fisher Scientific Inc. (US), Steris plc (US), and Paul Hartmann AG (Germany) have been identified as the key players in this market. |
April 2018 | $ 5650 |
|
Orthodontic Supplies Market by Product (Removable, Fixed Braces (Brackets (Self Ligating, Lingual), Archwire (Ni-Ti, Stainless Steel), Anchorage (Buccal Tube, Band), Ligature (Elastomeric, Wire)), Retainers), Patient, and Region - Global Forecast to 2023The global orthodontic supplies market is expected to reach USD 6.63 Billion by 2023 from USD 4.32 Billion in 2018, growing at a CAGR of 8.9%. The growing number of patients with malocclusions, jaw diseases, tooth decay/tooth loss, and jaw pain; increasing disposable incomes and expanding middle-class population in developing countries; increasing awareness about advanced orthodontic treatments; and ongoing research and technological advancements in orthodontic products are the key factors driving the growth of this market. The major players operating in the orthodontic supplies market include Align Technology, Inc. (US), 3M Company (US), Danaher Corporation (US), Henry Schien, Inc. (US), DENTSPLY SIRONA, Inc. (US), American Orthodontics (US), Rocky Mountain Orthodontics (US), G&H Orthodontics (US), DENTAURUM GmbH & Co. (Germany), TP Orthodontics, Inc. (US), ClearCorrect (a subsidiary of Straumann Holding AG, Switzerland), Ultradent Products, Inc. (US), Great Lakes Orthodontics, Ltd. (US), DB Orthodontics (UK), and Dental Morelli Ltda. (Brazil), among others. |
April 2018 | $ 5650 |
|
Neuroendoscopy Market by Product (Rigid (Videoscope, Fiberscope), Flexible endoscope), Usability (Reuse and Disposable), Application (Transnasal, Intraventricular, and Transcranial), Region (North America, Europe, Asia) - Global Forecast to 2022The global neuroendoscopy devices market is expected to reach USD 218.9 Million by 2022 from USD 170.5 Million in 2017, at a CAGR of 5.1% during the forecast period. Factors such favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market. The report segments the global neuroendoscopy devices market into product, application, usability, and region. The neuroendoscopy devices market includes various small and large players. Key players in this market are KARL STORZ (Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US). |
April 2018 | $ 5650 |
|
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM [ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker)], End User (Home and Ambulatory, Hospital) - Global Forecast to 2022The cardiac monitoring and cardiac rhythm management devices market is expected to reach USD 25.12 Billion by 2022 from USD 20.67 Billion in 2017, at a CAGR of 4.0% during the forecast period. The scope of the report includes cardiac monitoring and cardiac rhythm management devices used for the continuous monitoring, detection, and treatment of heart activities and abnormal heart rhythm (electric heart patterns). The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The cardiac monitoring and cardiac rhythm management devices market is dominated by players such as Medtronic (Ireland), Abbott (US), Boston Scientific (US), BIOTRONIK (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands) |
April 2018 | $ 5650 |
|
Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023The sepsis diagnostics market is expected to reach USD 564.1 Million by 2021 from USD 370.0 Million in 2016, at a CAGR of 8.8% during the forecast period. Rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and increase in the number of product approvals are supporting the growth of this market. However, lack of standard protocols and awareness as well as shortage of skilled staff are the major challenges in this market. The major players of the sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany). |
April 2018 | $ 5650 |
|
Infusion Pump Market by Product (Volumetric, Insulin, Enteral, Syringe, Ambulatory, Implantable, PCA, Accessories), Application (Oncology, Diabetes, Gastroenterology, Pediatrics, Hematology), End User (Hospital, Home Care, ACS) - Global Forecast to 2023The global infusion pumps market is projected to reach USD 15.89 Billion by 2023 from USD 11.90 Billion in 2018, growing at a CAGR of 6.0%. Factors such as the increasing prevalence of chronic diseases along with the rapid growth in the geriatric population, growing use of ambulatory infusion pumps in home care settings, and growing number of surgical procedures are driving the market growth. The prominent players in the infusion pumps market are Becton, Dickinson and Company (US), Baxter (US), ICU Medical (US), B. Braun (Germany), Fresenius Kabi (Germany), Medtronic (Ireland), Smiths Medical (US), Terumo Corporation (Japan), Moog (US), Roche Diagnostics (Switzerland), Halyard Health (US), Mindray Medical (China), Micrel Medical (Greece), and Insulet Corporation (US). |
April 2018 | $ 5650 |
|
Ophthalmic Equipment Market by Product (Optical Coherence Tomography (OCT), Fundus Camera, Ultrasound, Ophthalmoscope, Phoropter, Slit Lamp, Perimeter, Keratometer, Tonometer, IOL, Femtosecond Laser, Surgical Microscope, Contact Lenses) - Global Forecasts to 2023The ophthalmic equipment market is estimated to reach USD 58.44 Billion by 2023 from USD 49.30 Billion in 2018, at a CAGR of 3.5%. Rapid growth in the geriatric population and associated increase in the prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and rising adoption of contact lenses and spectacles are the major factors driving the growth of the market. However, the high-cost ophthalmic devices and reimbursement cuts for ophthalmic surgical procedures may hinder the growth of this market. Furthermore, the lack of awareness and low accessibility to eye care products in low-income economies is a major challenge for the growth of the ophthalmic equipment market. The prominent players in the ophthalmic equipment market are Essilor (France), Alcon (Switzerland), Johnson & Johnson Vision Care (US), Bausch + Lomb (US), Haag-Streit (Switzerland), TOPCON (Japan), Carl Zeiss Meditec (Germany), NIDEK (Japan), STAAR Surgical (US), HOYA (Japan), and Ziemer Ophthalmic Systems (Switzerland) |
March 2018 | $ 7150 |
|
Dental Implants and Prosthetics Market by Type (Dental Implants, Bridge, Crown, Abutment, Dentures, Veneers, Inlay & Onlays), Material (Titanium, Zirconium, Metal, Ceramic, Porcelain Fused to Metal), Type of Facility, and Region - Global Forecast to 2023The dental implants market is projected to reach USD 13.01 Billion by 2023 from USD 9.50 Billion in 2018, at a CAGR of 6.5%. The growth of this market is driven by the growth in the geriatric population and corresponding age-related dental diseases, rising prevalence of tooth decay and periodontal diseases in the overall population across the globe, increasing willingness to adopt dental cosmetic surgery, and the growing number of implant placing dentists. However, the high cost of premium dental implants and limited reimbursement, and high risk of tooth loss associated with dental bridges may expect to hinder the growth of this market during the forecast period. The key players in the global dental implants and prosthesis market are Straumann (Switzerland), DENTSPLY Sirona (US), Zimmer Biomet (US), Danaher Corporation (US), AVINENT Implant System (Spain), Henry Schein (US), OSSTEM Implant Co. (South Korea), DIO Corporation (South Korea), Merz Dental (Germany), Bicon (US), Shofu Dental Corporation (Japan), Thommen Medical (Switzerland), and Southern Implant (South Africa). |
March 2018 | $ 5650 |
|
Microfluidics Market by Application (Genomics, Proteomics, Capillary Electrophoresis, IVD (POC, Clinical Diagnostics), Drug Delivery, Microreactor, Lab Tests), Component (Chips, Pump, Needle), Material (Polymer, Glass, Silicon) - Global Forecast to 2023The global microfluidics market is projected to reach USD 27.91 Billion by 2023 from USD 10.06 Billion in 2018, at a CAGR of 22.6%. Rising demand for point-of-care testing due to the rising incidence of chronic infectious diseases, fast returns on investment on the purchase of equipment integrated with microfluidic technology, faster testing and improved portability through microfluidic chip miniaturization, and entry of new players with innovative microfluidics technology & launch of new and advanced products embedded with microfluidics technology are some of the major factors attributed to the growth of the microfluidics market during the forecast period. However, there are certain challenges in incorporating the microfluidics technology into existing workflows. The key players in the global microfluidics market are Danaher (US), Thermo Fisher (US), PerkinElmer (US), Agilent (US), Bio-Rad (US), Becton, Dickinson and Company (US), Roche (Switzerland), Illumina (US), Fluidigm Microfluidics (US), and QIAGEN (Netherlands). Other key players include Dolomite Microfluidics (UK), GYROS PROTEIN TECHNOLOGIES AB (Sweden), Sphere Fluidics (UK), OPKO Health (US), Waters (US), thinXXS Microtechnology (Germany), Abaxis (US), BioMérieux (France), Abbott (US), Dolomite Microfluidics (UK), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), Micronit Microtechnologies (Netherlands), MicroLiquid (Spain), MiniFAB (Australia), uFluidix (Canada), Micralyne (US), and Fluigent (France). |
March 2018 | $ 5650 |
|
In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023The global in vitro diagnostics market is projected to reach USD 87.93 Billion by 2023 from USD 68.12 Billion in 2018, at a CAGR of 5.2%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market. The prominent players in the global in vitro diagnostics market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany). |
March 2018 | $ 5650 |
|
Urgent Care Center Market by Service (Acute Illness Treatment, Trauma/Injury Treatment, Physical Examination, Immunization & Vaccination), Ownership (Corporate Owned, Physician Owned, Hospital Owned), and Region - Global Forecast to 2023The global urgent care center market is projected to reach USD 25.93 Billion by 2023 from USD 20.07 Billion in 2018, at a CAGR of 5.3% during the forecast period. The growth of this market is driven by factors such as growing investments in urgent care, increasing geriatric population, strategic developments between urgent care providers and hospitals, and affordable care and shorter waiting periods offered by urgent care centers. Concentra (US), MedExpress (US), American Family Care (US), NextCare Holdings (US), and FastMed Urgent Care (US) are the key players in the urgent care center market. Other players involved in this market are CityMD (US), CareNow Urgent Care (US), GoHealth Urgent Care (US), HCA Healthcare UK (UK), Columbia Asia Hospitals (India), International SOS (China), and St. Joseph's Health Care London (Canada). |
March 2018 | $ 5650 |
|
Medical Display Market by Technology (LED, OLED) Panel Size (≤22.9”, 27.0-41.9”, ≥42”) Resolution (≤2MP, 4.1-8MP, ≥8MP), Application (Radiology, Mammography, Digital Pathology, Multi-modality, Surgical), & Display color - Global Forecast to 2023The global medical display market is projected to reach USD 2.33 Billion by 2023 from USD 1.86 Billion in 2018, at a CAGR of 4.6%. Growing adoption of hybrid ORs, short replacement cycle of medical displays, increasing preference for minimally invasive treatments, and rising number of diagnostic imaging centers are the major factors driving the growth of the market. However, market saturation and the increased adoption of refurbished medical displays are expected to restrain the growth of this market to a certain extent. Prominent players in the healthcare medical display market include Barco (Belgium), EIZO (Japan), Sony (Japan), LG Display (South Korea), Novanta (US), FSN Medical (South Korea), Advantech (Taiwan), Quest International (US), STERIS (UK), Jusha Medical (China), Double Black Imaging (US), Dell (US), HP (US), Shenzhen Beacon Display (China), COJE Display (South Korea), and Axiomtek (Taiwan). |
March 2018 | $ 5650 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Live Chat Support
Search reports
Medical Devices ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Biotechnology ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
